Abstract:Highlights•Glioblastoma is the most common primary malignant brain tumor and is a challenging disease to treat.•The current standard of care includes surgical resection, followed by a combination of radiation and chemotherapy.•Glioblastoma has a high recurrence rate, urging scientists to continue to search for more effective treatment options.•Recent advances in therapy for glioblastoma include thermotherapy, nanotherapy, immunotherapy, phototherapy, and tumor treating fields.Glioblastoma multiforme (GBM) is one of the most common, most formidable, and deadliest malignant types of primary astrocytoma with a poor prognosis. At present, the standard of care includes surgical tumor resection, followed by radiation therapy concomitant with chemotherapy and temozolomide. New developments and significant advances in the treatment of GBM have been achieved in recent decades. However, despite the advances, recurrence is often inevitable, and the survival of patients remains low. Various factors contribute to the difficulty in identifying an effective therapeutic option, among which are tumor complexity, the presence of the blood-brain barrier (BBB), and the presence of GBM cancer stem cells, prompting the need for improving existing treatment approaches and investigating new treatment alternatives for ameliorating the treatment strategies of GBM. In this review, we outline some of the most recent literature on the various available treatment options such as surgery, radiotherapy, cytotoxic chemotherapy, gene therapy, immunotherapy, phototherapy, nanotherapy, and tumor treating fields in the treatment of GBM, and we list some of the potential future directions of GBM. The reviewed studies confirm that GBM is a sophisticated disease with several challenges for scientists to address. Hence, more studies and a multimodal therapeutic approach are crucial to yield an effective cure and prolong the survival of GBM patients.

Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions

The Advances in Targeted Therapy and Immunotherapy for Glioblastoma: Basic Research and Clinical Trials

Immunotherapy for glioblastoma: current state, challenges, and future perspectives

Emerging therapies for glioblastoma: current state and future directions

Immunotherapy of Glioblastoma: Recent Advances and Future Prospects

Current Immunotherapies for Glioblastoma Multiforme

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma

Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy

Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy

Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma

Immunotherapy: a promising approach for glioma treatment

Current approaches in glioblastoma multiforme immunotherapy

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future

Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme

Pharmacological strategies for improving the prognosis of glioblastoma

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma

Current State of Immune Checkpoints Therapy for Glioblastoma

Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives

Advances in Immunotherapy for Glioblastoma Multiforme

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions